These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 27343063)

  • 1. Adipose, Bone, and Myeloma: Contributions from the Microenvironment.
    McDonald MM; Fairfield H; Falank C; Reagan MR
    Calcif Tissue Int; 2017 May; 100(5):433-448. PubMed ID: 27343063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype.
    Fairfield H; Dudakovic A; Khatib CM; Farrell M; Costa S; Falank C; Hinge M; Murphy CS; DeMambro V; Pettitt JA; Lary CW; Driscoll HE; McDonald MM; Kassem M; Rosen C; Andersen TL; van Wijnen AJ; Jafari A; Reagan MR
    Cancer Res; 2021 Feb; 81(3):634-647. PubMed ID: 33218968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.
    Shay G; Hazlehurst L; Lynch CC
    J Mol Med (Berl); 2016 Jan; 94(1):21-35. PubMed ID: 26423531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow adiposity and multiple myeloma.
    Morris EV; Edwards CM
    Bone; 2019 Jan; 118():42-46. PubMed ID: 29548987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.
    Trotter TN; Gibson JT; Sherpa TL; Gowda PS; Peker D; Yang Y
    Am J Pathol; 2016 Nov; 186(11):3054-3063. PubMed ID: 27648615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-host cell interactions in the bone disease of myeloma.
    Fowler JA; Edwards CM; Croucher PI
    Bone; 2011 Jan; 48(1):121-8. PubMed ID: 20615487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment.
    Shay G; Tauro M; Loiodice F; Tortorella P; Sullivan DM; Hazlehurst LA; Lynch CC
    Oncotarget; 2017 Jun; 8(26):41827-41840. PubMed ID: 28611279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
    Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma.
    Abe M
    Int J Hematol; 2011 Oct; 94(4):334-343. PubMed ID: 22005835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma bone marrow niche.
    Basak GW; Srivastava AS; Malhotra R; Carrier E
    Curr Pharm Biotechnol; 2009 Apr; 10(3):345-6. PubMed ID: 19355944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microenvironment and molecular biology of the multiple myeloma tumor.
    Lemaire M; Deleu S; De Bruyne E; Van Valckenborgh E; Menu E; Vanderkerken K
    Adv Cancer Res; 2011; 110():19-42. PubMed ID: 21704227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloma-bone marrow adipocyte axis in tumour survival and treatment response.
    Jafari A; Fairfield H; Andersen TL; Reagan MR
    Br J Cancer; 2021 Sep; 125(6):775-777. PubMed ID: 33859343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma.
    Morris EV; Edwards CM
    J Cell Physiol; 2018 Dec; 233(12):9159-9166. PubMed ID: 29943829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to targeting the bone marrow microenvironment in multiple myeloma.
    Gooding S; Edwards CM
    Curr Opin Pharmacol; 2016 Jun; 28():43-9. PubMed ID: 27018230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites.
    Xu X; Zhang C; Trotter TN; Gowda PS; Lu Y; Ponnazhagan S; Javed A; Li J; Yang Y
    Cancer Res; 2020 Mar; 80(5):1036-1048. PubMed ID: 31911552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells.
    Falank C; Fairfield H; Reagan MR
    Front Endocrinol (Lausanne); 2016; 7():67. PubMed ID: 27379019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloma and Bone Disease.
    Panaroni C; Yee AJ; Raje NS
    Curr Osteoporos Rep; 2017 Oct; 15(5):483-498. PubMed ID: 28861842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokines and myeloma bone disease].
    Abe M
    Clin Calcium; 2014 Jun; 24(6):871-8. PubMed ID: 24870838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.
    Ribatti D; Nico B; Vacca A
    Int Rev Cell Mol Biol; 2015; 314():259-82. PubMed ID: 25619720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.